SGYP

Synergy Pharmaceuticals, Inc Common Stock
SGYP

Delisted

SGYP was delisted on the 7th of March, 2019.

149 hedge funds and large institutions have $291M invested in Synergy Pharmaceuticals, Inc Common Stock in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 52 increasing their positions, 40 reducing their positions, and 23 closing their positions.

Holders
149
Holders Change
+6
Holders Change %
+4.2%
% of All Funds
3.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
31
Increased
52
Reduced
40
Closed
23
Calls
$4.07M
Puts
$8.28M
Net Calls
-$4.2M
Net Calls Change
+$1.47M
Name Market Value Shares Shares
Change
Shares
Change %
BlackRock
1
BlackRock
New York
$49.1M 21,998,125 +1,761,725 +9%
State Street
2
State Street
Massachusetts
$45.6M 20,454,646 +7,276,438 +55%
Vanguard Group
3
Vanguard Group
Pennsylvania
$44.7M 20,034,327 +2,013,173 +11%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$31.9M 14,312,160 +11,782,938 +466%
NCM
5
Nantahala Capital Management
Connecticut
$15.6M 7,000,000 +7,000,000 New
PC
6
Paulson & Co
New York
$8.92M 4,000,000 -20,062,368 -83%
PAMU
7
Pictet Asset Management (UK)
United Kingdom
$6.93M 3,107,484 +495,948 +19%
Northern Trust
8
Northern Trust
Illinois
$6.5M 2,914,084 +157,639 +6%
JPMorgan Chase & Co
9
JPMorgan Chase & Co
New York
$6.16M 2,763,538 -641,839 -19%
UBS Group
10
UBS Group
Switzerland
$5.86M 2,626,977 -192,800 -7%
Citigroup
11
Citigroup
New York
$5.21M 2,338,167 +555,342 +31%
Deutsche Bank
12
Deutsche Bank
Germany
$4.82M 2,161,529 -222,471 -9%
Goldman Sachs
13
Goldman Sachs
New York
$4.52M 2,026,079 -1,291,591 -39%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$4.44M 1,988,935 -49,366 -2%
HP
15
Hikari Power
Japan
$4.24M 1,900,000 +400,000 +27%
Balyasny Asset Management
16
Balyasny Asset Management
Illinois
$3.74M 1,675,000 +291,600 +21%
Group One Trading
17
Group One Trading
Illinois
$3.39M 1,521,671 +414,275 +37%
IBT
18
International Biotechnology Trust
United Kingdom
$3.36M 1,505,804 +533,882 +55%
Morgan Stanley
19
Morgan Stanley
New York
$3.09M 1,384,046 -609,900 -31%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$2.41M 1,081,843 -89,215 -8%
Charles Schwab
21
Charles Schwab
California
$2.35M 1,051,408 +106,222 +11%
KCM
22
Kingdon Capital Management
New York
$2.32M 1,041,695 +272,555 +35%
HighTower Advisors
23
HighTower Advisors
Illinois
$1.79M 802,982 -42,282 -5%
TCIM
24
TIAA CREF Investment Management
New York
$1.33M 597,220 -636,636 -52%
Allianz Asset Management
25
Allianz Asset Management
Germany
$1.23M 549,837 -6,950 -1%